09/24/2026
The new edition of Hale’s Medications & Mothers’ Milk is here!
We’re so excited to announce the release of Hale’s Medications & Mothers’ Milk 2027–2028, led by Kaytlin Krutsch, PhD, PharmD, MBA, BCPS, Director of the InfantRisk Center.
For decades, Hale’s has been a trusted resource for clinicians caring for breastfeeding patients. This new edition brings together the latest research, clinical evidence, and real-world experience to help healthcare professionals make informed decisions about medications during lactation.
What’s new in the 2027–2028 edition:
• 75+ new drug monographs
• Expanded guidance on emerging therapies, including monoclonal antibodies and GLP-1 agents
• Enhanced clinical context informed by real-world InfantRisk Center consultations
• A new framework connecting maternal plasma levels with infant exposure
• Comprehensive information covering 1,300+ medications, diseases, vaccines, and syndromes
With practical tools, detailed drug monographs, Lactation Risk Categories, and quick-reference information, this edition continues the legacy of Thomas W. Hale while incorporating the latest advances in lactation pharmacology.
You can save 30% off the list price when ordering through Springer Publishing using code STUDYSM. Link below!
https://www.springerpub.com/hale-s-medications-mothers-milk-2027-2028-9780826178428.html?queryID=2b2294a8ce41e66f6e3cc9a0bbe3b476&objectID=16992&indexName=MAGE_CLD_PRD_springerpub_default_products